Galera Therapeutics Inc. (GRTX) NASDAQ

$0.20 0 (0.36%)

Market Cap: $10.66M

As of 05/17/24 04:00 PM EDT. Market closed.

(GRTX)

Galera Therapeutics Inc. (GRTX)
NASDAQ

$0.20
0 (0.36%)

Market Cap: $10.66M

As of 05/17/24 04:00 PM EDT. Market closed.

Add to Portfolio

galera therapeutics, inc. is a pharmaceuticals company located in 101 lindenwood dr, malvern, pennsylvania, united ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
41
Address
.
PRICE CHART FOR GALERA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.21
Previous Close
$0.20
Days Range
$0.19 - $0.23
52 week range
$0.09 - $3.59
Volume
981,387
Avg. Volume (30 days)
816,062
Market Cap
$10.66M
Dividend Yield
-
P/E
-
Shares Outstanding
54,392,170
Open
$0.21
Previous Close
$0.20
Days Range
$0.19 - $0.23
52 week range
$0.09 - $3.59
Volume
981,387
Avg. Volume (30 days)
816,062
Market Cap
$10.66M
Dividend Yield
-
P/E
-
Shares Outstanding
54,392,170
FINANCIAL STATEMENTS FOR GALERA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GALERA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Schneid Yair10% OwnerApr 19, 2024 Buy$0.19100,00019,39610,823,610May 01, 2024, 05:02 PM
Schneid Yair10% OwnerApr 18, 2024 Buy$0.20547,600107,39510,723,610May 01, 2024, 05:02 PM
Schneid Yair10% OwnerApr 17, 2024 Buy$0.221,814,657403,18510,176,010May 01, 2024, 05:02 PM
Schneid Yair10% OwnerApr 17, 2014 Buy$0.19318,15060,4488,361,353May 01, 2024, 05:02 PM
Schneid Yair10% OwnerFeb 06, 2024 Buy$0.2025,0005,0257,718,203Feb 26, 2024, 04:06 PM
Schneid Yair10% OwnerFeb 05, 2024 Buy$0.1897,40217,9227,693,203Feb 26, 2024, 04:06 PM
Schneid Yair10% OwnerJan 30, 2024 Buy$0.18335,00060,6357,595,801Feb 26, 2024, 04:06 PM
Schneid Yair10% OwnerJan 29, 2024 Buy$0.18150,00027,0007,260,801Feb 26, 2024, 04:06 PM
Schneid Yair10% OwnerFeb 08, 2024 Buy$0.17150,00025,6508,043,203Feb 26, 2024, 04:06 PM
Schneid Yair10% OwnerFeb 07, 2024 Buy$0.17175,00030,1857,893,203Feb 26, 2024, 04:06 PM
Bachleda MarkChief Commercial OfficerMar 16, 2023 Buy$2.2511,00024,71711,000Mar 20, 2023, 04:05 PM
Sorensen MelPresident and CEOMar 10, 2023 Buy$1.68100,000168,120332,044Mar 14, 2023, 08:30 AM
Degnan ChrisChief Financial OfficerMar 13, 2023 Buy$1.9610,00019,59310,000Mar 14, 2023, 08:30 AM
Beardsley Robert AChief Operating OfficerNov 21, 2022 Option Exercise$1.0710,00010,700108,191Nov 22, 2022, 04:05 PM
Beardsley Robert AChief Operating OfficerSep 12, 2022 Option Exercise$1.0710,00010,70098,191Sep 13, 2022, 04:10 PM
West LindaDirectorDec 17, 2021 Buy$2.7420,00054,80460,000Dec 20, 2021, 06:30 PM
Beardsley Robert AChief Operating OfficerDec 17, 2021 Option Exercise$1.0720,00021,40088,191Dec 20, 2021, 06:30 PM
HOLMLUND JON TChief Medical OfficerSep 01, 2021 Option Exercise$2.4347,756116,04747,756Sep 03, 2021, 04:31 PM
HOLMLUND JON TChief Medical OfficerSep 01, 2021 Sale$8.4747,756404,4980Sep 03, 2021, 04:31 PM
West LindaDirectorJun 15, 2021 Buy$9.1310,00091,30040,000Jun 17, 2021, 06:41 PM
Alleva Lawrence MDirectorJun 01, 2021 Buy$8.594,04534,7414,045Jun 03, 2021, 05:22 PM
West LindaDirectorJun 01, 2021 Buy$8.6410,00086,38120,000Jun 02, 2021, 05:35 PM
West LindaDirectorMay 28, 2021 Buy$8.6410,00086,41010,000Jun 02, 2021, 05:35 PM
Sorensen MelPresident and CEOMar 26, 2021 Option Exercise$1.09217,015235,492232,044Mar 30, 2021, 04:42 PM
Novo Holdings A/S10% OwnerFeb 18, 2021 Sale$10.58500,0005,290,0002,459,021Feb 19, 2021, 05:20 PM
Alleva Lawrence MDirectorNov 13, 2020 Buy$10.222,32523,7716,325Nov 17, 2020, 04:06 PM
Sussman Joel F.Chief Accounting OfficerNov 13, 2020 Option Exercise$1.4610,00014,55210,000Nov 16, 2020, 07:46 PM
Sussman Joel F.Chief Accounting OfficerNov 12, 2020 Option Exercise$1.0710,00010,70010,000Nov 16, 2020, 07:46 PM
Sussman Joel F.Chief Accounting OfficerNov 13, 2020 Sale$10.3210,000103,1970Nov 16, 2020, 07:46 PM
Sussman Joel F.Chief Accounting OfficerNov 12, 2020 Sale$10.0610,000100,6270Nov 16, 2020, 07:46 PM
HOLMLUND JON TChief Medical OfficerOct 26, 2020 Option Exercise$2.432,2445,4532,244Oct 28, 2020, 05:56 PM
HOLMLUND JON TChief Medical OfficerOct 26, 2020 Sale$15.002,24433,6600Oct 28, 2020, 05:56 PM
Novo Holdings A/S10% OwnerOct 15, 2020 Sale$11.00450,0004,950,0002,959,021Oct 19, 2020, 04:34 PM
HOLMLUND JON TChief Medical OfficerOct 06, 2020 Option Exercise$1.1110,53611,6685,632Oct 07, 2020, 05:01 PM
HOLMLUND JON TChief Medical OfficerOct 05, 2020 Option Exercise$1.07100107100Oct 07, 2020, 05:01 PM
HOLMLUND JON TChief Medical OfficerOct 06, 2020 Sale$12.0010,536126,4320Oct 07, 2020, 05:01 PM
HOLMLUND JON TChief Medical OfficerOct 05, 2020 Sale$12.001001,2000Oct 07, 2020, 05:01 PM
Novartis Bioventures LtdFormer 10% OwnerJun 18, 2020 Sale$9.049008,1363,469,273Jun 22, 2020, 04:52 PM
Novartis Bioventures LtdFormer 10% OwnerJun 19, 2020 Sale$8.251,001,3128,260,8242,467,961Jun 22, 2020, 04:52 PM
Novartis Bioventures Ltd10% OwnerJun 17, 2020 Sale$9.274,62242,8463,470,173Jun 17, 2020, 05:47 PM
Novartis Bioventures Ltd10% OwnerJun 16, 2020 Sale$9.308,60079,9803,474,795Jun 17, 2020, 05:47 PM
Novartis Bioventures Ltd10% OwnerJun 15, 2020 Sale$9.056,16455,7843,483,395Jun 17, 2020, 05:47 PM
Novartis Bioventures Ltd10% OwnerJun 12, 2020 Sale$9.191,50013,7853,489,559Jun 12, 2020, 06:33 PM
Novartis Bioventures Ltd10% OwnerJun 11, 2020 Sale$9.217,20066,3123,491,059Jun 12, 2020, 06:33 PM
Novartis Bioventures Ltd10% OwnerJun 10, 2020 Sale$9.468,53280,7133,498,259Jun 12, 2020, 06:33 PM
Novartis Bioventures Ltd10% OwnerJun 09, 2020 Sale$9.387,00065,6603,506,791Jun 09, 2020, 08:02 PM
Novartis Bioventures Ltd10% OwnerJun 08, 2020 Sale$9.665,65954,6663,513,791Jun 09, 2020, 08:02 PM
Novartis Bioventures Ltd10% OwnerJun 05, 2020 Sale$9.668,65283,5783,519,450Jun 09, 2020, 08:02 PM
Novartis Bioventures Ltd10% OwnerJun 04, 2020 Sale$9.554,08839,0403,528,102Jun 04, 2020, 05:36 PM
Novartis Bioventures Ltd10% OwnerJun 03, 2020 Sale$9.785,20850,9343,532,190Jun 04, 2020, 05:36 PM
Novartis Bioventures Ltd10% OwnerJun 02, 2020 Sale$9.685,66954,8763,537,398Jun 04, 2020, 05:36 PM
HOLMLUND JON TChief Medical OfficerMay 26, 2020 Option Exercise$1.07692740692May 28, 2020, 04:50 PM
HOLMLUND JON TChief Medical OfficerMay 26, 2020 Sale$12.006928,3040May 28, 2020, 04:50 PM
HOLMLUND JON TChief Medical OfficerMay 21, 2020 Option Exercise$1.071,1741,2561,174May 22, 2020, 05:20 PM
HOLMLUND JON TChief Medical OfficerMay 20, 2020 Option Exercise$1.079691,037969May 22, 2020, 05:20 PM
HOLMLUND JON TChief Medical OfficerMay 21, 2020 Sale$12.001,17414,0880May 22, 2020, 05:20 PM
HOLMLUND JON TChief Medical OfficerMay 20, 2020 Sale$12.0096911,6280May 22, 2020, 05:20 PM
HOLMLUND JON TChief Medical OfficerMay 12, 2020 Option Exercise$1.07671718671May 12, 2020, 07:00 PM
HOLMLUND JON TChief Medical OfficerMay 11, 2020 Option Exercise$1.07185198185May 12, 2020, 07:00 PM
HOLMLUND JON TChief Medical OfficerMay 08, 2020 Option Exercise$1.075,1025,4595,102May 12, 2020, 07:00 PM
HOLMLUND JON TChief Medical OfficerMay 11, 2020 Sale$12.001852,2200May 12, 2020, 07:00 PM
HOLMLUND JON TChief Medical OfficerMay 08, 2020 Sale$12.005,10261,2240May 12, 2020, 07:00 PM
HOLMLUND JON TChief Medical OfficerMay 12, 2020 Sale$12.006718,0520May 12, 2020, 07:00 PM
HOLMLUND JON TChief Medical OfficerMay 07, 2020 Option Exercise$1.072,0592,2032,059May 07, 2020, 07:12 PM
HOLMLUND JON TChief Medical OfficerMay 06, 2020 Option Exercise$1.071,4891,5931,489May 07, 2020, 07:12 PM
HOLMLUND JON TChief Medical OfficerMay 05, 2020 Option Exercise$1.073,0643,2783,064May 07, 2020, 07:12 PM
HOLMLUND JON TChief Medical OfficerMay 06, 2020 Sale$12.001,48917,8680May 07, 2020, 07:12 PM
HOLMLUND JON TChief Medical OfficerMay 05, 2020 Sale$12.163,06437,2580May 07, 2020, 07:12 PM
HOLMLUND JON TChief Medical OfficerMay 07, 2020 Sale$12.002,05924,7090May 07, 2020, 07:12 PM
Alleva Lawrence MDirectorDec 13, 2019 Buy$9.784,00039,1394,000Dec 17, 2019, 04:05 PM
Clarus IV-A, L.P.10% OwnerNov 12, 2019 Buy$12.00250,0003,000,000652,324Nov 14, 2019, 05:00 PM
Blackstone Clarus GP L.P.10% OwnerNov 12, 2019 Buy$12.00250,0003,000,000652,324Nov 14, 2019, 05:00 PM
Novo Holdings A/S10% OwnerNov 12, 2019 Buy$12.00500,0006,000,0003,409,021Nov 14, 2019, 02:16 PM
New Enterprise Associates 14, L.P.10% OwnerNov 12, 2019 Buy$12.00416,6664,999,9924,358,047Nov 12, 2019, 05:00 PM
Sofinnova Venture Partners IX, L.P.10% OwnerNov 12, 2019 Buy$12.00750,0009,000,0003,083,712Nov 12, 2019, 04:17 PM
Novartis Bioventures Ltd10% OwnerNov 12, 2019 Buy$12.00250,0003,000,0003,543,067Nov 12, 2019, 04:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Schneid Yair10% Owner04/19/202419,396
Schneid Yair10% Owner04/18/2024107,395
Schneid Yair10% Owner04/17/2024403,185
Schneid Yair10% Owner04/17/201460,448
Schneid Yair10% Owner02/06/20245,025
Schneid Yair10% Owner02/05/202417,922
Schneid Yair10% Owner01/30/202460,635
Schneid Yair10% Owner01/29/202427,000
Schneid Yair10% Owner02/08/202425,650
Schneid Yair10% Owner02/07/202430,185
Bachleda MarkChief Commercial Officer03/16/202324,717
Sorensen MelPresident and CEO03/10/2023168,120
Degnan ChrisChief Financial Officer03/13/202319,593
Beardsley Robert AChief Operating Officer11/21/202210,700
Beardsley Robert AChief Operating Officer09/12/202210,700
West LindaDirector12/17/202154,804
Beardsley Robert AChief Operating Officer12/17/202121,400
HOLMLUND JON TChief Medical Officer09/01/2021116,047
HOLMLUND JON TChief Medical Officer09/01/2021404,498
West LindaDirector06/15/202191,300
Alleva Lawrence MDirector06/01/202134,741
West LindaDirector06/01/202186,381
West LindaDirector05/28/202186,410
Sorensen MelPresident and CEO03/26/2021235,492
Novo Holdings A/S10% Owner02/18/20215,290,000
Alleva Lawrence MDirector11/13/202023,771
Sussman Joel F.Chief Accounting Officer11/13/202014,552
Sussman Joel F.Chief Accounting Officer11/12/202010,700
Sussman Joel F.Chief Accounting Officer11/13/2020103,197
Sussman Joel F.Chief Accounting Officer11/12/2020100,627
HOLMLUND JON TChief Medical Officer10/26/20205,453
HOLMLUND JON TChief Medical Officer10/26/202033,660
Novo Holdings A/S10% Owner10/15/20204,950,000
HOLMLUND JON TChief Medical Officer10/06/202011,668
HOLMLUND JON TChief Medical Officer10/05/2020107
HOLMLUND JON TChief Medical Officer10/06/2020126,432
HOLMLUND JON TChief Medical Officer10/05/20201,200
Novartis Bioventures LtdFormer 10% Owner06/18/20208,136
Novartis Bioventures LtdFormer 10% Owner06/19/20208,260,824
Novartis Bioventures Ltd10% Owner06/17/202042,846
Novartis Bioventures Ltd10% Owner06/16/202079,980
Novartis Bioventures Ltd10% Owner06/15/202055,784
Novartis Bioventures Ltd10% Owner06/12/202013,785
Novartis Bioventures Ltd10% Owner06/11/202066,312
Novartis Bioventures Ltd10% Owner06/10/202080,713
Novartis Bioventures Ltd10% Owner06/09/202065,660
Novartis Bioventures Ltd10% Owner06/08/202054,666
Novartis Bioventures Ltd10% Owner06/05/202083,578
Novartis Bioventures Ltd10% Owner06/04/202039,040
Novartis Bioventures Ltd10% Owner06/03/202050,934
Novartis Bioventures Ltd10% Owner06/02/202054,876
HOLMLUND JON TChief Medical Officer05/26/2020740
HOLMLUND JON TChief Medical Officer05/26/20208,304
HOLMLUND JON TChief Medical Officer05/21/20201,256
HOLMLUND JON TChief Medical Officer05/20/20201,037
HOLMLUND JON TChief Medical Officer05/21/202014,088
HOLMLUND JON TChief Medical Officer05/20/202011,628
HOLMLUND JON TChief Medical Officer05/12/2020718
HOLMLUND JON TChief Medical Officer05/11/2020198
HOLMLUND JON TChief Medical Officer05/08/20205,459
HOLMLUND JON TChief Medical Officer05/11/20202,220
HOLMLUND JON TChief Medical Officer05/08/202061,224
HOLMLUND JON TChief Medical Officer05/12/20208,052
HOLMLUND JON TChief Medical Officer05/07/20202,203
HOLMLUND JON TChief Medical Officer05/06/20201,593
HOLMLUND JON TChief Medical Officer05/05/20203,278
HOLMLUND JON TChief Medical Officer05/06/202017,868
HOLMLUND JON TChief Medical Officer05/05/202037,258
HOLMLUND JON TChief Medical Officer05/07/202024,709
Alleva Lawrence MDirector12/13/201939,139
Clarus IV-A, L.P.10% Owner11/12/20193,000,000
Blackstone Clarus GP L.P.10% Owner11/12/20193,000,000
Novo Holdings A/S10% Owner11/12/20196,000,000
New Enterprise Associates 14, L.P.10% Owner11/12/20194,999,992
Sofinnova Venture Partners IX, L.P.10% Owner11/12/20199,000,000
Novartis Bioventures Ltd10% Owner11/12/20193,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN GALERA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKSTONE INC.1,678,9840.00095%No changeOther
GEODE CAPITAL MANAGEMENT, LLC440,3490.00001%No changeOther
BLACKROCK INC.357,1920%-0.12%Other
RENAISSANCE TECHNOLOGIES LLC313,5000.00007%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR GALERA THERAPEUTICS INC
STOCK BUYBACKS FOR GALERA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
09/30/2023
19.60%
2Q
03/31/2024
06/30/2023
26.74%
3Q

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
19.60%
2Q
06/30/2023
26.74%
3Q
BUYBACK ANNOUNCEMENT(S) FOR GALERA THERAPEUTICS INC
LOADING...